Influence of route of administration on targeting ovarian cancer tissue with chimeric monoclonal antibody MOv18 (c-MOv18)

C.F.M. Molthoff; P. Kenemans; A. van Hof; M.R. Buist; RHM Verheijen; W. den Hollander; J.B Vermorken; J.C. Roos

Influence of route of administration on targeting ovarian cancer tissue with chimeric monoclonal antibody MOv18 (c-MOv18)

C.F.M. Molthoff, P. Kenemans, A. van Hof, M.R. Buist, RHM Verheijen, W. den Hollander, J.B Vermorken, J.C. Roos

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 1994
Event	8th NCI-EORTC Symposium on New Drugs in Cancer Therapy - Amsterdam, Netherlands Duration: 14 Oct 1994 → …

Conference

Conference	8th NCI-EORTC Symposium on New Drugs in Cancer Therapy
Country/Territory	Netherlands
City	Amsterdam
Period	14/10/94 → …

Cite this

@conference{34163859b1174496ac4c42e72e1ea000,

title = "Influence of route of administration on targeting ovarian cancer tissue with chimeric monoclonal antibody MOv18 (c-MOv18)",

author = "C.F.M. Molthoff and P. Kenemans and {van Hof}, A. and M.R. Buist and RHM Verheijen and {den Hollander}, W. and J.B Vermorken and J.C. Roos",

year = "1994",

language = "English",

note = "8th NCI-EORTC Symposium on New Drugs in Cancer Therapy ; Conference date: 14-10-1994",

}

TY - CONF

T1 - Influence of route of administration on targeting ovarian cancer tissue with chimeric monoclonal antibody MOv18 (c-MOv18)

AU - Molthoff, C.F.M.

AU - Kenemans, P.

AU - van Hof, A.

AU - Buist, M.R.

AU - Verheijen, RHM

AU - den Hollander, W.

AU - Vermorken, J.B

AU - Roos, J.C.

PY - 1994

Y1 - 1994

M3 - Abstract

T2 - 8th NCI-EORTC Symposium on New Drugs in Cancer Therapy

Y2 - 14 October 1994

ER -